启动子 ATP依赖的染色质重塑复合物与肺癌研究进展(6)

[9] Yoshimoto T，Matsubara D，Nakano T，et al.Frequent loss of the expression of multiple subunits of the SWI/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung[J].Pathology International，2015，65（11）：595.

[10] Rodriguez-Nieto S，Canada A，Pros E，et al.Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors[J].Hum Mutat，2011，32（2）：E1999-E2017.

[11] Zhou Z，Su Y，Xianen F.Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b[J].Oncotargets & Therapy，2015，8：3603-3612.

[12] Tagal V，Wei S，Zhang W，et al.SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor

VX-680 in non-small cell lung cancers[J].Nature Communications，2017，8：14098.

[13] Fillmore C M，Xu C，Desai P T，et al.EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoⅡ inhibitors[J].Nature，2015，520（7546）：239.

[14] Bell E H，Chakraborty A R，Mo X，et al.SMARCA4/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2015，22（10）：2396.

[15] Herpel E，Rieker R J，Dienemann H，et al.SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer：immunohistochemical survey of 316 consecutive specimens[J].Annals of Diagnostic Pathology，2017，26：47-51.endprint

[16] Fukuoka J，Fujii T，Shih J H，et al.Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer[J].Clin Cancer Res，2004，10（13）：4314-4324.